JP2019500034A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019500034A5 JP2019500034A5 JP2018531240A JP2018531240A JP2019500034A5 JP 2019500034 A5 JP2019500034 A5 JP 2019500034A5 JP 2018531240 A JP2018531240 A JP 2018531240A JP 2018531240 A JP2018531240 A JP 2018531240A JP 2019500034 A5 JP2019500034 A5 JP 2019500034A5
- Authority
- JP
- Japan
- Prior art keywords
- aav
- optionally
- raav
- gnptab
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021210071A JP2022046635A (ja) | 2015-12-15 | 2021-12-24 | ムコリピドーシスｉｉ型を治療するためのアデノ随伴ウイルスベクター |
| JP2024019140A JP2024056832A (ja) | 2015-12-15 | 2024-02-13 | ムコリピドーシスｉｉ型を治療するためのアデノ随伴ウイルスベクター |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562267502P | 2015-12-15 | 2015-12-15 | |
| US62/267,502 | 2015-12-15 | ||
| PCT/US2016/066611 WO2017106313A1 (en) | 2015-12-15 | 2016-12-14 | Adeno-associated viral vectors for treating mucolipidosis type ii |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021210071A Division JP2022046635A (ja) | 2015-12-15 | 2021-12-24 | ムコリピドーシスｉｉ型を治療するためのアデノ随伴ウイルスベクター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019500034A JP2019500034A (ja) | 2019-01-10 |
| JP2019500034A5 true JP2019500034A5 (https=) | 2020-01-30 |
| JP7347932B2 JP7347932B2 (ja) | 2023-09-20 |
Family
ID=57737987
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018531240A Active JP7347932B2 (ja) | 2015-12-15 | 2016-12-14 | ムコリピドーシスｉｉ型を治療するためのアデノ随伴ウイルスベクター |
| JP2021210071A Pending JP2022046635A (ja) | 2015-12-15 | 2021-12-24 | ムコリピドーシスｉｉ型を治療するためのアデノ随伴ウイルスベクター |
| JP2024019140A Pending JP2024056832A (ja) | 2015-12-15 | 2024-02-13 | ムコリピドーシスｉｉ型を治療するためのアデノ随伴ウイルスベクター |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021210071A Pending JP2022046635A (ja) | 2015-12-15 | 2021-12-24 | ムコリピドーシスｉｉ型を治療するためのアデノ随伴ウイルスベクター |
| JP2024019140A Pending JP2024056832A (ja) | 2015-12-15 | 2024-02-13 | ムコリピドーシスｉｉ型を治療するためのアデノ随伴ウイルスベクター |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20200261598A1 (https=) |
| EP (1) | EP3390644B1 (https=) |
| JP (3) | JP7347932B2 (https=) |
| KR (1) | KR102833376B1 (https=) |
| CN (1) | CN108603199A (https=) |
| AU (2) | AU2016372035B2 (https=) |
| CA (1) | CA3008268A1 (https=) |
| ES (1) | ES2991277T3 (https=) |
| IL (1) | IL259964B (https=) |
| MX (1) | MX2018007330A (https=) |
| RU (1) | RU2742612C2 (https=) |
| SG (2) | SG11201804994QA (https=) |
| WO (1) | WO2017106313A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2020118342A (ru) | 2017-11-07 | 2021-12-08 | Дзе Юниверсити Оф Норт Каролина Эт Чепел Хилл | Оптимизированные гены aga и экспрессионные кластеры и их применение |
| AU2019385506A1 (en) * | 2018-11-21 | 2021-06-03 | Takeda Pharmaceutical Company Limited | Recombinant viral vectors and nucleic acids for producing the same |
| AU2020366242A1 (en) * | 2019-10-18 | 2022-05-26 | Research Institute At Nationwide Children's Hospital | Materials and methods for the treatment of disorders associated mutations in the IRF2BPL gene |
| MY209860A (en) | 2020-02-13 | 2025-08-07 | Tenaya Therapeutics Inc | Gene therapy vectors for treating heart disease |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5478745A (en) * | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| US6995006B2 (en) | 1997-09-05 | 2006-02-07 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| CN1213768C (zh) * | 1998-04-27 | 2005-08-10 | 联邦高等教育系统坦普尔大学 | 治疗内毒素血症的方法 |
| US6537785B1 (en) * | 1999-09-14 | 2003-03-25 | Genzyme Glycobiology Research Institute, Inc. | Methods of treating lysosomal storage diseases |
| US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
| NZ532635A (en) | 2001-11-13 | 2007-05-31 | Univ Pennsylvania | A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method |
| JP2005523942A (ja) * | 2002-04-30 | 2005-08-11 | アヴィオル セラピューティクス インコーポレイテッド | 免疫療法のためのアデノウイルスベクター |
| WO2004075861A2 (en) | 2003-02-26 | 2004-09-10 | Children's Hospital, Inc. | Recombinant adeno-associated virus production |
| DE602004030327D1 (de) | 2003-05-21 | 2011-01-13 | Genzyme Corp | Verfahren zur herstellung von präparationen rekombinanter aav-virionen, die weitgehend frei von leeren capsiden sind |
| US8283151B2 (en) | 2005-04-29 | 2012-10-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes |
| US7588772B2 (en) | 2006-03-30 | 2009-09-15 | Board Of Trustees Of The Leland Stamford Junior University | AAV capsid library and AAV capsid proteins |
| PL3252161T3 (pl) * | 2007-06-06 | 2022-03-07 | Genzyme Corporation | Terapia genowa dla lizosomalnych chorób spichrzeniowych |
| HUE028341T2 (en) | 2009-06-16 | 2016-12-28 | Genzyme Corp | Improved methods for purification of recombinant aav vectors |
| SMT201600385T1 (it) * | 2010-06-25 | 2017-03-08 | Shire Human Genetic Therapies | Trasporto di agenti terapeutici all’snc |
| US8663624B2 (en) | 2010-10-06 | 2014-03-04 | The Regents Of The University Of California | Adeno-associated virus virions with variant capsid and methods of use thereof |
| DK2675902T3 (da) | 2011-02-17 | 2019-06-03 | Univ Pennsylvania | Sammensætninger og fremgangsmåder til at ændre vævsspecificitet og forbedre aav9-medieret genoverførsel |
| MX384795B (es) * | 2013-03-15 | 2025-03-14 | Childrens Hospital Philadelphia | Vectores que comprenden secuencias de polinucleotidos rellenadoras/de relleno y metodos de uso. |
| CN120174012A (zh) * | 2013-10-24 | 2025-06-20 | 优尼科Ip有限公司 | 用于基因治疗神经疾病的aav-5假型载体 |
| IL248102B (en) * | 2014-05-02 | 2022-07-01 | Genzyme Corp | aav vectors for gene therapy of the central nervous system and retina |
-
2016
- 2016-12-14 IL IL259964A patent/IL259964B/en unknown
- 2016-12-14 CA CA3008268A patent/CA3008268A1/en active Pending
- 2016-12-14 KR KR1020187019970A patent/KR102833376B1/ko active Active
- 2016-12-14 JP JP2018531240A patent/JP7347932B2/ja active Active
- 2016-12-14 WO PCT/US2016/066611 patent/WO2017106313A1/en not_active Ceased
- 2016-12-14 AU AU2016372035A patent/AU2016372035B2/en active Active
- 2016-12-14 EP EP16822578.7A patent/EP3390644B1/en active Active
- 2016-12-14 MX MX2018007330A patent/MX2018007330A/es unknown
- 2016-12-14 SG SG11201804994QA patent/SG11201804994QA/en unknown
- 2016-12-14 ES ES16822578T patent/ES2991277T3/es active Active
- 2016-12-14 US US16/061,579 patent/US20200261598A1/en active Pending
- 2016-12-14 CN CN201680081705.8A patent/CN108603199A/zh active Pending
- 2016-12-14 RU RU2018124448A patent/RU2742612C2/ru active
- 2016-12-14 SG SG10201912935WA patent/SG10201912935WA/en unknown
-
2021
- 2021-12-24 JP JP2021210071A patent/JP2022046635A/ja active Pending
-
2023
- 2023-06-28 AU AU2023204116A patent/AU2023204116B2/en active Active
-
2024
- 2024-02-13 JP JP2024019140A patent/JP2024056832A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102200642B1 (ko) | 유전자 치료를 위한 변형된 프리드라이히 운동실조증 유전자 및 벡터 | |
| ES2230569T3 (es) | Funciones accesorias para uso en la produccion de viriones aav recombinantes. | |
| JP6174318B2 (ja) | アデノ随伴ウイルス構築物を含んでなるコンダクティング気道細胞を標的とするための組成物 | |
| EP1828390B1 (en) | Chimeric vectors | |
| JP2022126765A5 (https=) | ||
| JP6363958B2 (ja) | Ａａｖ変異体 | |
| JP2024009857A5 (https=) | ||
| JP2021523718A5 (https=) | ||
| JP2021003120A5 (https=) | ||
| JP2020048571A5 (https=) | ||
| CN116096431A (zh) | 肽修饰的aav衣壳 | |
| JP2017509632A5 (https=) | ||
| JP2018522529A5 (https=) | ||
| JP2020522269A5 (https=) | ||
| JP2018506261A5 (https=) | ||
| ES2210391T3 (es) | Sistema auxiliar de alta eficacia para la produccion de vectores aav. | |
| JP2022046635A5 (https=) | ||
| JP2017529395A5 (https=) | ||
| JP2019500034A5 (https=) | ||
| CN111876432B (zh) | 一组肝靶向新型腺相关病毒的获得及其应用 | |
| JPWO2019152609A5 (https=) | ||
| RU2018124448A (ru) | Векторы на основе аденоассоциированного вируса для лечения муколипидоза типа ii | |
| JPWO2021050614A5 (https=) | ||
| CN112011571A (zh) | 一种用于治疗脊髓性肌萎缩的基因治疗药物 | |
| JPWO2023201274A5 (https=) |